Follow us...

 

Search News Archives

News Channels

 

Coronavirus (COVID-19)

 

 

View Channel

New Laboratory Products

 

View Channel

Lab News

 

View Channel

Research & Case Studies

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Videos

 

View Channel

Events | Webinars

 

View Channel

Conferences | Events

Inside a state-of-the-art automated high-content screening lab

publication date: Oct 26, 2020
 | 
author/source: Molecular Devices

inside-stateoftheart-automated-highcontent-screening


HCS Pharma uses ImageXpress Micro Confocal Systems for phenotypic screening of physiologically relevant 3D cell models

HCS Pharma is a biotechnology start-up focused on in vitro preclinical research and development. The company specializes in multi-parametric cell imaging assays using High-Content Analysis (HCA) and High-Content Screening (HCS) approaches. This allows them to save time and money by investigating several different parameters within the same experiment. The team, led by Nathalie and Grégory Maubon, performs both primary and secondary screens and develops new assays and 2D/3D cell culture models. These can be used for services in different application areas such as toxicology, pharmacology, dermo-cosmetics and nutraceutics.

HCS Pharma creates innovative 3D cellular models which enable researchers to perform phenotypic screening on more relevant 3D cellular assays that also consider the extracellular matrix (ECM). To reach this goal, HCS Pharma has recently acquired BIOMIMESYS® technology, which is a unique and natural hyaluronic acid-based hydroscaffold, biofunctionalized with other ECM components to better mimic the microenvironment of every organ!

The team needed to implement 3D confocal imaging using powerful and reliable high-throughput systems that could be integrated within a robotic platform, allowing high-throughput imaging. Specifically, the team needed:

  • Confocal imaging to perform 3D reconstructions
  • A high signal-to-noise ratio to maximize acquisition speed
  • A fully integrated platform, from incubators to imagers
  • Imaging software to perform high-throughput 3D image analysis

We needed a solution which would maximize the rentability of our studies by enabling us to offer more parameter extractions in less time”, says Nathalie Maubon.

See how the team save time and money with automated High-Content Screening (HCS) and imaging approaches, in collaboration with Molecular Devices.

 

View Case Study

Learn more - cell imaging systems

more news from Molecular Devices


 


If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 

 

 

Media Partners